ArticleFrontiers in immunology2022
Case Report: Rapid Desensitization to Ocrelizumab for Multiple Sclerosis Is Effective and Safe.
Marcelo Vivolo Aun et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
2022
this papercites it